AUG 20, 2014 7:15 AM PDT

Establishing cell-free biology for the production of therapeutics, materials, and chemicals

Speaker

Abstract

Imagine a world in which we could adapt biology to manufacture any therapeutic, material, or chemical from renewable resources, both quickly and on demand. Industrial biotechnology is one of the most attractive approaches for addressing this need, particularly when large-scale chemical synthesis is untenable. Unfortunately, the fraction of biobased products amenable to economical production is limited because engineering whole-cell microorganisms with synthetic pathways remains costly and slow. We hypothesize that a key problem to these efforts lies with the inherent limitations imposed by cells. Microbial cells exist to produce more cells, not to produce items of commerce, which often are an unnecessary or even toxic burden on the primary cellular objectives of growth and adaptation. This leads to a variety of challenges afflicting the current state-of-the-art, including: low yields and productivities, build-up of toxic intermediates or products, and byproduct losses via competing pathways. To overcome these limitations, we are expanding the scope of the traditional engineering model in biotechnology by using cell-free systems to harness ensembles of catalytic proteins prepared from crude lysates, or extracts, of cells for the production of target products. Rather than attempt to balance the tug-of-war between the cells objectives and the engineers objectives, we are developing new paradigms for designing, building, and testing cell-free systems that harness and modify biological systems involved in protein synthesis and metabolism. In this presentation, I will discuss our efforts to develop cost-effective, high-throughput cell-free protein synthesis platforms, expand the chemistry of life using non canonical amino acids, construct and evolve synthetic ribosomes, and produce sustainable chemicals with ultrahigh productivities. Our work is enabling a deeper understanding of why natures designs work the way they do and opening new frontiers for biomanufacturing.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
OCT 21, 2021 9:00 AM PDT
C.E. CREDITS
OCT 21, 2021 9:00 AM PDT
Date: October 21, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Industry guidelines for host cell protein impurity analysis emphasize the importance of process-specific and product-specific assessm...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
AUG 24, 2021 11:00 AM PDT
C.E. CREDITS
AUG 24, 2021 11:00 AM PDT
Date: August 24, 2021 Time: 11:00am (PDT), 1:00pm (EDT) Electron-based dissociation mechanisms have shown great promise for advanced characterization of biomolecules. However, routine adopti...
AUG 20, 2014 7:15 AM PDT

Establishing cell-free biology for the production of therapeutics, materials, and chemicals



Show Resources
Loading Comments...
Show Resources